LOADING
Comparing Broadcom Inc (AVGO) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.99T | $307.2B |
| P/E Ratio | 69.7 | 36.0 |
| Forward P/E | 20.8 | 48.3 |
| PEG Ratio | 0.44 | 12.06 |
| EPS | $6.00 | $3.55 |
| Revenue Growth (YoY) | 47.9% | 4.9% |
| Profit Margin | 38.9% | 13.6% |
| Return on Equity | 37.3% | 18.9% |
| Dividend Yield | 0.65% | 2.52% |
| Beta | 1.47 | 0.21 |
| 52-Week High | $494.18 | $135.05 |
| 52-Week Low | $279.80 | $75.81 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.